37,000+ AI agents form a 'Virtual Biotech' in Science, forecasting clinical trial success
EricTopol · x · 2026-09-23
Eric Topol highlights "Virtual Biotech," published in Science (James Zou's group): over 37,000 AI agents were organized to operate like a virtual biotech company, discovering drug targets and forecasting clinical trial success — covering both efficacy and side-effect avoidance. It's the first in a series of accomplishments.
The New York Times covered the work today, framing it as a landmark for AI-driven drug development.
More from Research
- CypherGuard fixes structurally wrong LLM Cypher queries, hitting 88.5% on CypherBench — JeremyCMorgan · 2026-11-12
- PufferLib 5.0 trains a Rubik's Cube solver at 8.8M SPS on a single 12GB GPU — haydendevs · 2026-11-11
- 10-line deterministic polynomial-time primality test relies on OpenAI's recent quasi-GRH result, making AKS obsolete — fortnow · 2026-11-11
- WSP Weight Edits Shown Equivalent to Constrained Activation Steering on Qwen — kastnerkyle · 2026-11-11
- codec.audio benchmarks neural audio codecs on noisy in-the-wild speech; MOSS tops — kastnerkyle · 2026-11-11
- Sparse Rewiring owl-persona eval vs full SFT released with weights, data, code — maxsloef · 2026-11-11